8-K ·Filed Jul 16, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
Monitor for August 2026 first dosing announcement of SLIM-1; no immediate financial impact, but successful initiation would be a positive milestone for this pre-revenue biotech.
Final — all horizons settled through T+60d
VANI ▼ -7.41% at T+60d
NEUTRAL call -7.41% · α vs SPY -11.12% · entry $1.35 → $1.25
T+1d
-2.22%
call -2.22% · α -1.23%
$1.32
settled 3mo ago
T+5d
+2.96%
call +2.96% · α +4.63%
$1.39
settled 3mo ago
T+20d
-0.74%
call -0.74% · α -4.36%
$1.34
settled 3mo ago
T+60d
-7.41%
call -7.41% · α -11.12%
$1.25
settled 18d ago
Price Chart
Loading chart...
Executive Summary
Vivani Medical disclosed via an 8-K that its CEO presented at the Emerging Growth Conference, updating that first dosing of the SLIM-1 trial is expected in August 2026. This is a routine clinical timeline update with no financial data.
Key Facts
- First dosing of SLIM-1 expected in August 2026
- CEO Dr. Adam Mendelsohn presented at Emerging Growth Conference on July 15, 2026
Financial Impact
No financial data provided in the filing
Risk Factors
- SLIM-1 dosing may be delayed beyond August 2026
- No financial or operational updates beyond timeline
Market Snapshot
Exchange
Nasdaq
Analyst Consensus
90% bullish (10 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001753926-26-001190 |
| Document: 0001753926-26-001190-index-headers.html | 0001753926-26-001190 |
| Document: 0001753926-26-001190-index.html | 0001753926-26-001190 |
| Document: 0001753926-26-001190.txt | 0001753926-26-001190 |
8 reports for VANI
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | 424B5 | $1.25 $1.13 | ▲ +9.60% | ▲ +9.57% | $1.14 (+8.80%) |
Aug 17, 2026 10w ago | 8-K | $1.35 $1.23 | ▼ −8.89% | ▼ −6.91% | $1.14 (−15.56%) |
Jul 16, 2026 14w ago | 8-K | $1.35 $1.34 | ▼ −0.74% | ▼ −4.36% | $1.14 (−15.56%) |
Jul 7, 2026 16w ago | 8-K | $1.35 $1.33 | ▼ −1.48% | ▼ −2.81% | $1.14 (−15.56%) |
Jul 2, 2026 16w ago | Press Release | $1.26 $1.30 | ▲ +3.17% | ▲ +3.59% | $1.14 (−9.52%) |
Jun 30, 2026 17w ago | 8-K | $1.24 $1.30 | ▲ +4.84% | ▲ +5.87% | $1.14 (−8.06%) |
Jun 4, 2026 20w ago | 8-K | $1.28 $1.26 | ▼ −1.56% | ▼ −0.19% | $1.14 (−10.94%) |
Mar 26, 2026 30w ago | Press Release | $1.02 $1.39 | ▲ +36.27% | ▲ +23.53% | $1.14 (+11.76%) |
Showing 8 of 8
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers